INTRODUCTION {#SEC1}
============

Early embryonic development requires the establishment of complex and diverse cellular and tissue systems, characterized by tightly-controlled, spacio-temporal patterns of gene expression. However, the precise molecular mechanisms which direct this asymmetry within the early embryo remain poorly understood. The importance of gradients of 'morphogens' in this process has long been suggested ([@B1]). These are biological substances that diffuse between cells, and act to generate specific responses, dependent upon their concentrations (reviewed in ([@B2])). Before the establishment of the circulatory system, mammalian development occurs under relatively low levels of O~2~ (estimated to be between 2% and 8%; reviewed in ([@B3],[@B4])), and the availability of O~2~ is determined by its diffusion. This will give rise to micro-gradients of O~2~ and more hypoxic niches within the early embryo ([@B5],[@B6]). The functional significance of the levels of O~2~ in the regulation of cellular differentiation has been demonstrated and found to be both concentration- and context-dependent. Thus, several studies have demonstrated that the levels of available O~2~ can act to promote the differentiation of certain types of stem or progenitor cells and yet inhibit the differentiation of others (reviewed in ([@B4])). Therefore O~2~ can be considered to be a developmental morphogen that can influence cell fate in a manner akin to gradients of secreted growth factors such as members of the Transforming Growth Factor-β superfamily ([@B7]).

The term 'epigenetics' has come to be defined as changes in gene expression, and hence cell function, that are not determined by DNA sequence (reviewed in ([@B8])), and to a large extent this involves the reorganisation of chromatin structure to mediate the accessibility of specific gene loci to their cognate transcription factors. During development, changes to the chromosomal architecture act to determine gene expression patterns and ultimately determine cell fate ([@B8]). These chromosomal changes are primarily facilitated by two dynamically regulated processes; the methylation/demethylation of cytosine, primarily at CpG dinucleotides ([@B9]) and the post-translational modification of histone tails ([@B10]). The establishment of cell specificity and fate (and therefore the initiation of epigenetic changes) originates from the first stages of embryogenesis. Intriguingly, epigenetic modifying enzymes which act to demethylate both histones and 5-methylcytosine (5mC) are 2-oxoglutarate-(2-OG)-dependent, Fe^2+^-dependent dioxygenases, which display an absolute requirement for molecular oxygen ([@B11]). In the case of DNA demethylation, this is achieved by the successive oxidation of 5mC, by the Ten-Eleven-Translocation family of dioxygenases (Tets) resulting in the formation of 5-hydroxymethylcytosine (5hmC), 5-formylcytosine (5fC) and 5-carboxylcytosine (5caC) ([@B12]). DNA repair mechanisms can subsequently excise 5fC and 5caC which then become replaced by unmethylated cytosine, in an 'active' demethylation process. Alternatively, the oxidised methylcytosines can be lost in a replication-dependent, 'passive' mechanism ([@B15]). However, 5hmC is not committed to spontaneous subsequent oxidation and demethylation, and hence also represents a stable epigenetic modification with specific regulatory functions which are increasingly being elucidated ([@B16],[@B17]).

There are three Tet enzymes ([@B13]), which display tissue-specific and developmental-stage specific patterns of expression in mammalian cells ([@B18]). Consistently, significant expression of Tet1 and Tet2 has been reported in undifferentiated embryonic stem cells (ESCs) ([@B13],[@B21]), while Tet3 expression is low in undifferentiated ESCs, becomes induced during ESC differentiation ([@B18],[@B21],[@B25]), and is known to be enriched in both developing and mature neuronal cell lineages ([@B20],[@B25],[@B26]). Loss-of-function studies both *in vitro* and *in vivo* have demonstrated these enzymes to serve both overlapping and distinct roles in the maintenance of ESC pluripotency ([@B13],[@B27]) and also in cellular specification and transcriptional fidelity during development ([@B13],[@B21],[@B25],[@B31]). However, the possibility that O~2~ gradients may mediate distinct cellular differentiation pathways, regulated in part *via* the differential regulation of these epigenetic modifiers, has not been investigated.

We here demonstrate that during the earliest stages (3 days) of mouse ESC (mESC) differentiation *in vitro*, a transient burst of (global) 5hmC, mediated specifically by Tet1, is apparent under atmospheric O~2~ levels, but is inhibited in O~2~-poor (1%) culture conditions, which are physiologically relevant within the early developing embryo. Unexpectedly, the most significant target of the \[O~2~\]-dependent 5mC- hydroxylation during these early stages of ESC differentiation was identified as a promoter region of *Tet3*. Culture of differentiating ESCs under 1% O~2~ acted to prevent 5mC-hydroxylation at this *Tet3* promoter, and inhibited significantly the induction of Tet3 mRNA transcription later during ESC differentiation, concomitant with a loss in some molecular markers of neural lineages. These data therefore demonstrate the potential role of O~2~ gradients within the early embryo to regulate epigenetic changes and cellular differentiation *via* the differential modulation of the activity of Tet1.

MATERIALS AND METHODS {#SEC2}
=====================

Cell culture {#SEC2-1}
------------

Human Embryonic kidney cells (HEK-293T) were cultured in high-glucose Dulbecco\'s modified Eagle\'s medium (DMEM) supplemented with 10% fetal bovine serum (FBS) (Sigma) and 2 mM [l]{.smallcaps}-glutamine, 100 U/ml penicillin, streptomycin 100 μg/ml solution (Sigma). Cells were transfected with Tet-overexpression plasmids were gifts from Anjana Rao, obtained from Addgene (Tet1:49792, Tet2:41710, Tet3:49446) and pcDNA™ 3.1 (Invitrogen) using Lipofectamine™-2000 (Invitrogen). All plasmids encode full-length, unmutated human (Tet1 and Tet3) or mouse (Tet2) proteins which have been fully sequenced ([@B22],[@B37],[@B38]). R1 mouse embryonic stem cells (mESCs), (kindly provided by Dr. Shukry Habib), were maintained undifferentiated on 0.1% gelatin coated flasks in DMEM/F12 (Invitrogen) containing 8 μM 2-mercaptomethanol, 2 mM GlutaMAX-I™ (Invitrogen), 100 U/ml penicillin and 100 μg/ml streptomycin (Invitrogen), supplemented with 10% EmbryoMax FBS (Millipore), 20 ng/ml leukemia inhibitory factor (LIF; Millipore), 3 μM CHIR-99021 (Sigma), 1 μM PD0325901 (Sigma) and 5μg/ml plasmocin prophylactic (InvivoGen). Stable knockdown mESCs were generated from MISSION® shRNA lentiviral transduction particles (Sigma): Tet1 (TRCN0000341849), Tet2 (TRCN0000192770), Tet3 (TRCN0000376843) and MISSION^®^ pLKO.1-puro non-targeted shRNA control (SHC016V-1). Cells were infected in the presence of 10 μg/ml polybrene (Sigma) and selected and maintained with 1 μg/ml puromycin (Invitrogen), 72-h post-infection. Unbiased mESC-induction to embryoid bodies was performed by culture in non-adherent petri dishes in KnockOut DMEM (Invitrogen) containing 15% KnockOut serum replacement (Invitrogen), 0.1 mM MEM amino acid solution (Invitrogen) and 2 mM GlutaMax-I (ThermoFisher). Cells were exposed to low \[O~2~\] in a ProOx C21 regulated C-chamber (BioSpherix) positioned inside a 37°C humidified incubator. Desired \[O~2~\] was achieved by N~2~ balance, in 5% \[CO~2~\]. 1 mM Dimethyloxaloylglycine (DMOG) (Sigma) was used as hypoxia-mimetic.

RNA purification and qPCR analysis {#SEC2-2}
----------------------------------

Total RNA was extracted using the ReliaPrep™ RNA Tissue miniprep system (Promega). For the mouse cell lineage identification, RT^2^ profiler PCR array (Qiagen), triplicate samples were pooled and 400 ng RNA reverse transcribed with M-MLV RT (Promega). Relative gene expression using SYBR green (PCR Biosystems) was performed on a ViiA™ 7 system (Applied Biosystems) and quantified using the comparative C~t~ method. β-Actin was selected for normalization. For other analyses, 1 μg RNA was reverse transcribed and quantified on a StepOnePlus™ system (Applied Biosystems). Canx was used for normalisation, selected using the geNorm™ reference selection kit (Primerdesign). qPCR primer sequences are shown in Table [1](#tbl1){ref-type="table"}.

###### Primer list

  qPCR             Forward 5′-3′                    Reverse 5′-3′
  ---------------- -------------------------------- ---------------------------
  Tet1             GAGCCTGTTCCTCGATGTGG             CAAACCCACCTGAGGCTGTT
  Tet2             TGTTGTTGTCAGGGTGAGAATC           TCTTGCTTCTGGCAAACTTACA
  Tet3             CCGGATTGAGAAGGTCATCTAC           AAGATAACAATCACGGCGTTCT
  Oct4             GTTGGAGAAGGTGGAACCAA             CTCCTTCTGCAGGGCTTTC
  Nanog            AAGGATGAAGTGCAAGCGGT             GGTGCTGAGCCCTTCTGAAT
  Gdf3             CTTCTCCCAGACCAGGGTTTT            TCTAGAGTCAGCTGGGCCAT
  Lefty1           CAGCTCGATCAACCGCCAGT             GGCTGGCATGGCTGTGTT
  Dnmt3b           CCCTCCCCCATCCATAGT               TCTGCTGTCTCCCTTCATTGT
  Sox7             AGATGCTGGGAAAGTCATGG             AGAGGGAGCTGAGGAGGAAG
  Hnf4a            ACACCACCCTGGAGTTTGAA             GCCCAGGCTGTTGGATGAAT
  Gata2            CTCCAGCTTCACCCCTAAGC             ACCACAGTTGACACACTCCC
  Hand1            CGGAAAAGGGAGTTGCCTCA             GGTGCGCCCTTTAATCCTCT
  Nppa             CAACACAGATCTGATGGATTTCA          CCTCATCTTCTACCGGCATC
  Myh7             AGCAGCAGTTGGATGAGCGACT           CCAGCTCCTCGATGCGTGCC
  Hes5             CCCAAGGAGAAAAACCGACT             TGCTCTATGCTGCTGTTGATG
  Sox2             GCACATGAACGGCTGGAGCAACG          TGCTGCGAGTAGGACATGCTGTAGG
  Dcx              ACGACCAAGACGCAAATGGA             CTTGTGCTTCCGCAGACTTC
  Fabp7            AACCAGCATAGATGACAGAAACTG         ACTTCTGCACATGAATGAGCTT
  Canx             TTCCAGACCCTGATGCAGA              TCCCATTCTCCGTCCATATC
  **hMeDIP**                                        
  Tet3             GAGAGGGCATAGCGGACTTG             GCAGACTGCAGATGAGTGGA
  **TrueMethyl**                                    
  Tet3             GATTTTTTTTAGAAGAGAAATTTGTTTAAG   CAAACCAAATCAATCCTCCCTA
  **ChiP**                                          
  Tet3             GGGTCATCTGGTGGATCTTC             GACACCGCTAGAACACAGCA

Antibodies {#SEC2-3}
----------

Antibodies used: 5hmC (Active Motif, 39770), 5mC (Active Motif, 39649), H3K27me3 (Active Motif, 39155), and H3K4me3 (Cell Signalling, 9751), Tet1 (Millipore, 09-872), FLAG (Sigma, F3165), α-tubulin (Sigma, T5168).

DNA extraction and immuno-dot-blot analyses {#SEC2-4}
-------------------------------------------

Genomic DNA was prepared by 350 μg/ml proteinase K (Sigma) digestion in 15 mM NaCl, 1%SDS, 100 mM EDTA, 50 mM Tris--HCl pH 8 at 55°C for 4 h. Samples were sonicated (Branson 150 sonfier) to obtain 200--1000 bp fragments and RNaseA (140 μg/ml; Qiagen) digested at 55°C for 30 min. DNA was phenol/chloroform extracted and ethanol precipitated. 2 μg of DNA was applied to Hybond™-N (GE Healthcare) using a dot-blot hybridisation manifold (Cleaver Scientific) as described in ([@B39]). Known DNA standards (Active Motif) were included as a measure of antibody specificity. Membranes were blocked in 10% milk PBS/T or Odyssey Blocking Buffer (PBS) (Li-Cor) and probed with 5hmC or 5mC antibodies respectively overnight. Blots were developed and quantified using an Odyssey® CLx imaging system (Li-Cor).

Mass spectrometry {#SEC2-5}
-----------------

One microgram of genomic DNA was digested with DNA degradase plus (Zymo Research) as described previously ([@B40]) Samples were four times diluted and injected into Agilent 1100 LC system interfaced directly to Waters Quattro LC triple quadrupole mass spectrometer for C, 5mC and 5hmC detection.

^1^H NMR assessment of metabolites {#SEC2-6}
----------------------------------

HEK-293Ts were washed in ice-cold PBS and scraped into metabolite extraction buffer (methanol:choloroform:H~2~O; 1:1:1). The methanol/H~2~O phase was evaporated under a SpeedVac™ concentrator (Thermo Scientific) at 30°C. Dried extracts were reconstituted in 100 mM sodium monophosphate buffer (pH 7.0) containing 500 μM TMSP (sodium 3-(trimethylsilyl)propionate-2,2,3,3-d4), 1.5 mM NaN~3~, 0.5 mM EDTA and 100% D~2~O. A 700 MHz Bruker spectrometer equipped with cryogenic probe was used for 1D ^1^H NMR data acquisition with suppressed water resonance. ^1^H NMR spectra were acquired using 9.3 kHz spectral width and 32 K data points with acquisition time of 1.67 s, relaxation delay of 5 s and 128 scans. Resulting spectra were processed to 65 536 data point and corrected for phasing and zero referencing using NMRLab ([@B41]). Resonance assignments and quantification were made with reference to Chenomx NMR Suite 7.1 (Chenomx). Samples were normalised to total protein, determined by a Bradford assay (Thermo Scientific).

5hmC DNA-Immunoprecipitation (hMeDIP)-Seq/PCR {#SEC2-7}
---------------------------------------------

hMeDIP (Active Motif) was performed on 1 μg of fragmented genomic DNA, pooled from triplicate samples, according to manufacturer\'s instructions. Libraries were prepared from the test sample (day 3-differentiated mESCs grown under atmospheric O~2~; 2.5 ng), and equivalent amount of control, total genomic DNA using NEBNext Ultra II DNA Library Prep Kit for Illumina (New England Biolabs; E7645), following the manufacturer\'s protocol. DNA fragments were end-repaired and ligated to adaptors. Fragments with 200 bp inserts were size selected using Agencourt Ampure XP Beads (Beckman Coulter), eluted in 10 mM Tris, and indexed and amplified by PCR for 12 cycles. The libraries were quantified by qPCR using NEBNext Library Quant Kit for Illumina (New England Biolabs; E7630), and pooled at 4 nM concentration. The library pool was sequenced on the MiSeq single read for 50 cycles. Data was analysed using BaseSpace (Illumina) and Galaxy (<https://usegalaxy.org/>).

PCR amplification of the *Tet3* promoter region (primer sequences shown in Table [1](#tbl1){ref-type="table"}) from day 3-differentiated mESCs exposed to atmospheric and 1% O~2~ was performed in a 50 μl reaction volume using Q5^®^ high fidelity DNA polymerase (New England Biolabs), as per the manufacturer\'s protocol, with the addition of Enhancer buffer. Samples were amplified for 30 cycles using a 64°C annealing temperature. PCR products were visualized by agarose gel-electrophoresis.

TrueMethyl genome analysis (bisulfite and oxidative-bisulfite sequencing) {#SEC2-8}
-------------------------------------------------------------------------

Four hundred nanogram genomic DNA from undifferentiated and day 3-differentiated mESCs were processed through the TrueMethyl^®^ Whole Genome kit (CEGX) protocol. Samples were split evenly to enable parallel quantification of 5mC and 5hmC using bisulfite and oxidative-bisulfite chemistry respectively. The *Tet3* promoter fragment (primer sequences shown in Table [1](#tbl1){ref-type="table"}, designed using [epidesigner.com](http://epidesigner.com)) was amplified using KAPA HiFi HS Uracil PCR ready mix (Kapa Biosystems) under manufacture\'s conditions. Samples were amplified for 35 cycles using a 60°C annealing temperature. PCR products were analysed by agarose gel-electrophoresis and extracted for Sanger Sequencing (Source Bioscience).

Chromatin-immunoprecipitation (ChIP) {#SEC2-9}
------------------------------------

Undifferentiated and day 3-differentiated mESCs were fixed in 1% formaldehyde (Sigma), harvested, lysed and sonicated as described for immuno-dot-blot analyses. ChIP assays were performed using the EZ-Magna ChIP™ (Millipore) kit according to manufacturer\'s instructions, using negative control IgG and antibodies to H3K27me3, H3K4me3 or Tet1. PCR amplification of the *Tet3* promoter region (primer sequences shown in Table [1](#tbl1){ref-type="table"}) was performed in 25 μl reaction volumes using Q5^®^ high fidelity DNA polymerase, according to the manufacturer\'s instructions, with added Enhancer buffer. H3K27me3 and H3K4me3 were amplified for 28 cycles and Tet1 for 30 cycles, at a 66°C annealing temperature and 30 s extension time.

Western blotting {#SEC2-10}
----------------

Protein samples were prepared as described previously ([@B42]). 30 μg were loaded onto 7.5% SDS-polyacrylamide gels and transferred to a nitrocellulose membrane (GE Healthcare). Blots were blocked in 10% milk TBS/T and probed overnight with a FLAG antibody at the supplier\'s recommended conditions. Blots were visualised and quantified on an Odyssey® CLx imaging system (Li-Cor). Blots were probed with α-tubulin (1/10 000 dilution) to evidence equal loading ([Supplementary Figure S1](#sup1){ref-type="supplementary-material"}).

RESULTS {#SEC3}
=======

Lowered \[O~2~\] changes the pattern of mESC differentiation {#SEC3-1}
------------------------------------------------------------

Although precise levels of O~2~ are challenging to measure directly i*n vivo*, most estimates suggest the mammalian uterine environment under which the embryo develops to be in the range of 2--8% (reviewed in ([@B3])). Further, before the development of the circulatory system, cells within some embryonic compartments likely experience \[O~2~\] significantly below this, and, indeed, \[O~2~\] within some stem cell niches have been reported to be as low as 1% ([@B6]). We sought to determine the effect of O~2~-poor culture conditions (1% O~2~), upon the determination of cell-fate of a population of mESCs, allowed to differentiate into all three germ layers without bias. mESCs were grown for 7 days under atmospheric (∼21%) or 1% O~2~ and the mRNA expression profiles of a panel of genes, representative of pluripotency and all three germ layers was assessed using a cell-lineage qPCR array (Figure [1](#F1){ref-type="fig"}). The mRNA levels of a representative selection of these markers were further validated by independent qPCR. Overall, the expression patterns of all endodermal markers tested displayed little sensitivity to altered O~2~ levels (less than 2-fold change in any case; Figure [1B](#F1){ref-type="fig"}), while some early mesodermal markers, such as Hand1 ([@B43]) and Gata2 ([@B44]) showed a marked increase (\>5-fold; Figure [1C](#F1){ref-type="fig"}) in 1% O~2~. The expression of later mesodermal markers, including the cardiac markers Myh7 and Nppa ([@B45]), were not increased and remained low at this early differentiation time-point. By contrast, many early ectodermal markers, and in particular markers of neuronal progenitor cells, such as Dcx ([@B46]), displayed a marked decrease in their expression, in response to lowered O~2~ levels (Figure [1D](#F1){ref-type="fig"}). Finally, the expression levels of all the genes tested which are characteristic of pluripotent ESCs, including Oct4 and Nanog ([@B47]), were significantly increased in response to lowered \[O~2~\] (Figure [1A](#F1){ref-type="fig"}). These data suggest that low \[O~2~\] acts both to maintain the undifferentiated state, and additionally skews the differentiation of a population of mESCs away from more ectodermal (and specifically neuronal) lineages, towards a more mesodermal fate.

![1% O~2~ changes the pattern of mESC differentiation. mESCs were differentiated for 7 days in atmospheric and 1% O~2~ and a cell lineage qPCR profiler array was performed upon pooled triplicate mRNA samples to give relative quantification of expression of (**A**) pluripotency genes, (**B**) endodermal-expressed genes, (**C**) mesodermal-expressed genes and (**D**) ectodermal-expressed genes (including neuronal progenitor markers). Data represent mRNA levels from 1% O~2~-cultured mESCs, as a fold-change relative to corresponding expression in atmospheric O~2~, depicted by the dotted line (set at 1 in each case). Independent qPCR-validation of a representative selection of genes is displayed as the mean ± SEM, analysed by an unpaired *t-*test. \**P* \< 0.05, \*\**P* \< 0.01, \*\*\**P* \< 0.001, \*\*\*\**P* \< 0.0001.](gkx1197fig1){#F1}

Tet enzymes are potential oxygen sensors {#SEC3-2}
----------------------------------------

We sought to determine whether the changes in mRNA expression, induced by low (1%) \[O~2~\] in the differentiating mESCs might in part be mediated *via* Tet(s). It was thus necessary to establish whether the activities of the Tet enzyme(s) might be influenced by changes in \[O~2~\] over a range considered physiological in differentiating ESCs. Plasmid constructs expressing Tet1, Tet2 or Tet3 were transiently transfected into human embryonic kidney cells (HEKs), and subsequently cultured under atmospheric conditions, together with a graded set of different O~2~ levels, ranging from 0.5% to 5%. In addition, as a control, cells (at atmospheric \[O~2~\]) were incubated with 1 mM dimethyloxalylglycine (DMOG), a competitive inhibitor of 2-OG-dependent dioxygenases. The relative global levels of 5hmC and 5mC were measured by immuno-dot-blot to give a measure of Tet activity in each case (Figure [2B](#F2){ref-type="fig"} and [C](#F2){ref-type="fig"}). In addition, specific samples were additionally assessed for absolute levels of 5hmC, 5mC and C by mass spectrometry (Figure [2D](#F2){ref-type="fig"}). As shown in Figure [2A](#F2){ref-type="fig"}, the levels of 5hmC in HEKs (which were barely detectable) were shown to increase significantly upon ectopic expression of each Tet (under atmospheric conditions), although the activity resulting from Tet2 overexpression appeared significantly higher than that resulting from Tet1 or Tet3. Successful transfection and expression of each Tet enzyme was additionally demonstrated by western-blot analyses, which also indicated that the expression of Tet2, relative to Tet1 or Tet3 was not increased in these experiments, further suggesting that the catalytic *activity* of Tet2 was significantly higher, or more promiscuous than Tet1 or Tet3 ([Supplementary Figure S1](#sup1){ref-type="supplementary-material"}).

![Tet1/2/3 are differentially regulated by \[O~2~\]. (**A**) Immuno-dot-blot and quantification of levels of 5hmC resulting from HEKs transfected with pcDNA control, or Tet1/2/3-containing expression plasmids and cultured under atmospheric O~2~ for 48 h. Known DNA standards were included to validate antibody specificity. Histograms depict levels of 5hmC, relative to control levels (arising from pcDNA-transfected cells). (**B**) Representative immuno-dot-blot depicting 5hmC and 5mC levels in HEKs after Tet1/2/3-overexpression (as indicated) and culture under atmospheric or 0.5% O~2~ for 48 h. **C:** Quantification of immuno-dot-blot analyses of HEK cells after Tet1/2/3-overexpression and culture for 48 h under atmospheric O~2~, and under O~2~ concentrations ranging from 0.5% to 5% as indicated. Cells grown under atmospheric O~2~ in 1 mM DMOG served as a positive control. Histograms depict the ratio of 5hmC:5mC, in each case shown relative to the level observed after culture under atmospheric O~2~ (100%). (**D**) Mass-spectrometry analyses of 5hmC levels in HEK cells cultured under atmospheric, 3% and 0.5% O~2~ for 48 h. Histograms depict MS peak intensity of 5hmC, normalized to total C, shown in each case relative to the level observed after culture under atmospheric O~2~ (100%). (**E**) ^1^H NMR analyses of levels of metabolites (as indicated) in HEKs after culture under atmospheric, 3% and 1% O~2~ for 48 h. Data are expressed as the mean ± SEM, and either analysed by a *t*-test or one-way ANOVA with Tukey\'s *post-hoc* analysis. \**P* \< 0.05, \*\**P* \< 0.01, \*\*\**P* \< 0.001, \*\*\*\**P* \< 0.0001.](gkx1197fig2){#F2}

The data in Figure [2C](#F2){ref-type="fig"} and [D](#F2){ref-type="fig"} clearly demonstrate that the activity of Tet1 was not altered by culture in 5%, compared to atmospheric, O~2~, but was inhibited significantly upon culture at 3%, and lower O~2~ levels. Contrasting with this, the activity of Tet2 displayed no inhibition of activity at either 5% or 3% O~2~, and in fact was only marginally affected during culture under O~2~ levels as low as 0.5%, or by DMOG-inhibition. Surprisingly, although not significantly changed at 5% O~2~ (compared to atmospheric conditions), the activity of Tet3 was found to be *enhanced* at 3% O~2~, but then decreased during culture under 1% and 0.5% O~2~. It is, however, well established that the activities of the Tet enzymes have a requirement for 2-OG and can also be antagonised by high levels of sterically-similar TCA metabolites; succinate and fumarate ([@B48]). Culturing cells under different levels of O~2~ will affect their metabolic fluxes, and consequently the intracellular levels of all these TCA metabolites. To further investigate a potential cause of the unexpected increase in Tet3 activity under more hypoxic conditions, a metabolic profile of HEKs was determined by ^1^H NMR after culture in 3% and 1% O~2~, and compared to that seen under atmospheric conditions (Figure [2E](#F2){ref-type="fig"}). Lactate levels increased under lowered O~2~ conditions, consistent with the activation of glycolysis, and decreased oxidative phosphorylation and TCA cycle activity. In addition, levels of glutamate (from which 2-OG can be derived, to have an anaplerotic effect on the TCA cycle) were reduced in both 3% and 1% O~2~. Together, these findings suggest a decrease in levels of 2-OG, which might be expected to inhibit further the activities of the Tets under enhanced hypoxia. However, both succinate and fumarate levels were significantly decreased in 3%, compared to atmospheric, O~2~, which could in part account for *increased* Tet3 activity at this point. However, when cultured at 1% O~2~, succinate levels in HEKs had increased back to atmospheric O~2~ levels (although fumarate levels remained low) and this may have acted in part to inhibit further the activity of Tet3 at 1% O~2~, compared to 3% O~2~, as we observed.

Irrespective of the precise mechanism underlying the biphasic response of Tet3 activity to increasing levels of hypoxia, we conclude that the activities of the Tet enzymes are differentially regulated by O~2~ levels. We also conclude that Tet1 activity, specifically, is potentially differentially inhibited by low, graded levels of O~2~ which are physiologically relevant within the developing mammalian embryo.

Global levels of 5hmC are dynamically regulated during early mESC differentiation and are inhibited by low \[O~2~\] {#SEC3-3}
-------------------------------------------------------------------------------------------------------------------

The levels of 5mC and 5hmC within undifferentiated ESCs are known to be highly dependent upon the conditions under which they are cultured, and consequently there are differing reports of these levels within the literature ([@B21],[@B22],[@B49]). In particular, inhibition of MEK and Gsk3β by two small molecule inhibitors ('2i' conditions, as employed in these studies), results in a hypomethylated state, with consequent low levels of 5hmC. It has been shown that this better represents the epigenetic state of inner cell mass cells of the very early (preimplantation) blastocyst, compared to ESCs classically-grown without 2i ([@B49]). We determined the genome-wide levels of both 5mC and 5hmC in undifferentiated mESCs grown under 2i conditions, and subsequently in these mESCs induced to differentiate under atmospheric conditions over a time-course of 11 days. We demonstrated that 5hmC levels were low in these undifferentiated mESCs, but upon differentiation they exhibited a 'burst' of 5hmC, which was apparent by day 1 and which peaked at day 3 before subsequently subsiding to day 9 (Figure [3A](#F3){ref-type="fig"}). By contrast, the 5mC levels increased sharply at day 3 and subsequently reached a plateau by day 5. Thus, perhaps surprisingly, the increase in the stable genome-wide levels of 5mC did not appear to precede the burst of 5hmC. This might suggest that this burst of hydroxymethylation occurs at already existing 5mC residues, or that the methylation and hydroxymethylation reactions are tightly coupled at this specific stage of mESC differentiation. To determine the effect of \[O~2~\] upon this burst of 5hmC generation, mESCs were induced to differentiate over the same time scale (0--11 days) in 3% and 1% O~2~. Intriguingly, this transient burst of genome-wide 5hmC was not affected at 3% O~2~, but was significantly blunted by culture under 1% O~2~ (Figure [3B](#F3){ref-type="fig"} and [C](#F3){ref-type="fig"}).

![Levels of 5-hmC are dynamically regulated during mESC differentiation. (**A**) 5hmC and 5mC levels detected by mass-spectrometry in mESCs differentiated over 11 days, cultured under atmospheric O~2~ at time points as indicated. Histograms depict MS peak intensities of 5hmC or 5mC, normalized to total C, shown in each case relative to the level observed in undifferentiated cells. Data expressed as the mean ± SEM and analysed by a one-way ANOVA with Dunnett\'s *post-hoc* test to levels in undifferentiated mESCs. (**B**) Immuno-dot-blot analyses of 5hmC levels in mESCs differentiated over 11 days at time points as indicated, cultured under atmospheric, 3% or 1% O~2~. Histograms depict levels of 5hmC, in each case shown relative to the level observed in undifferentiated mESCs in atmospheric O~2~. (**C**) Mass spectrometry analyses of samples as in (**B)**. Histograms depict MS peak intensity of 5hmC, normalized to total C, shown in each case relative to the level observed in undifferentiated cells in atmospheric O~2~. Data expressed as the mean ± SEM and analysed by a two-way ANOVA with Bonferroni\'s *post-hoc* test.\**P* \< 0.05, \*\**P* \< 0.01, \*\*\**P* \< 0.001, \*\*\*\**P* \< 0.0001.](gkx1197fig3){#F3}

The burst of 5hmC in differentiating ESCs is mediated by Tet1 {#SEC3-4}
-------------------------------------------------------------

We assessed the mRNA levels of each Tet enzyme over this time-course of early mESC differentiation, in order to determine which Tet isoform may be catalysing the observed burst of (\[O~2~\]-dependent) 5hmC at day3. However, consistent with other reports ([@B21],[@B22]), none of the expression profiles of the Tets appeared to mirror the dynamic changes in global 5hmC levels observed. Indeed, mRNA expression levels of both Tet1 and Tet2 were observed to *decline* significantly, concomitant with the increase in 5hmC levels, while the expression of Tet3 remained low until *after* the burst in 5hmC had subsided (Figure [4A](#F4){ref-type="fig"}). However, at day 3 (when 5hmC levels were highest) Tet1 was significantly (approximately 40-fold) more highly expressed than Tet2, which was itself ∼5-fold more highly expressed than Tet3 (Figure [4B](#F4){ref-type="fig"}).

![Tet1 mediates the burst of 5hmC in differentiating mESCs at day 3. (**A**) qPCR analyses of Tet1, Tet2 and Tet3 mRNA expression in mESCs over a time course of differentiation in atmospheric O~2~ as indicated. Levels are normalised to Canx, and shown relative to the levels observed in undifferentiated mESCs in each case. (**B**) Relative levels of Tet 1--3 mRNA expression, normalised to Canx, in mESCs at day 3 of differentiation. Levels are shown relative to Tet1 mRNA expression. (**C**) Immuno-dot-blot analyses of 5hmC in undifferentiated or day 3-differentiated mESCs cultured under atmospheric O~2~, stably-infected with control, or shRNAs directed to Tet 1--3, to generate Tet1--3 knockdown (KD) mESCs. Histograms depict levels of 5hmC, in each case shown relative to the level observed in undifferentiated, control mESCs. (**D**) Mass-spectrometry analyses of samples as in (C). Histograms depict MS peak intensity of 5hmC, normalised to total C, shown in each case relative to the level observed in undifferentiated, control mESCs. **E:** Immuno-dot-blot analyses of 5hmC levels in undifferentiated or day 3-differentiated, control or Tet1 KD mESCs, and in control mESCs, differentiated for 3 days under 1% O~2~. Histograms depict levels of 5hmC, in each case shown relative to that observed in undifferentiated, control mESCs under atmospheric O~2~. Data expressed as the mean ± SEM and analysed by either a one-way ANOVA with Dunnett\'s or Tukey *post-hoc* test or two-way ANOVA with Dunnett\'s *post-hoc* test. \**P* \< 0.05, \*\**P* \< 0.01, \*\*\**P* \< 0.001, \*\*\*\**P* \< 0.0001.](gkx1197fig4){#F4}

To determine which Tet enzyme was functional in mediating this transient increase in 5hmC, stably transformed mESCs were generated in which the expression of Tet1, Tet2 or Tet3 was down-regulated by shRNA-expressing lentiviral infection. In each case successful gene silencing was demonstrated by qPCR ([Supplementary Figure S2](#sup1){ref-type="supplementary-material"}). Downregulation of Tet1, specifically, acted to decrease significantly the levels of 5hmC, both in undifferentiated mESCs and at day 3 of mESC differentiation to the levels seen in 1% O~2~-cultured cells (Figure [4C](#F4){ref-type="fig"}--[E](#F4){ref-type="fig"}). We thus conclude that the burst of genome-wide 5hmC, observed upon the induction of mESCs to differentiate, is mediated *via* Tet1-dependent activity, in an \[O~2~\]-dependent and time-dependent manner.

Downregulation of Tet1 acts to inhibit mESC differentiation {#SEC3-5}
-----------------------------------------------------------

The effect of Tet1-downregulation upon the mRNA expression of pluripotent and lineage-specific genes was investigated. Tet1-depleted mESCs were induced to differentiate for 7 days, and their profiles of expression were compared to control shRNA-infected cells. As shown in Figure [5A](#F5){ref-type="fig"}, silencing of Tet1 acted to increase the expression of all the pluripotency genes analysed, as was observed when mESCs were cultured in 1% O~2~, although the relative changes in gene expression were less marked, and did not always reach significance. Tet1-depletion also acted to change the relative expression levels of many early differentiation markers, but it did *not* skew differentiation away from the ectodermal/neuronal lineages and towards mesodermal lineages, (as was evident in mESCs grown under 1% O~2~). Rather, the changes in gene expression of lineage-specific genes were highly variable, and did not demonstrate a consistent trend towards (or away from) a profile characteristic of any specific germ layer or cell lineage (Figure [5B](#F5){ref-type="fig"}).

![Tet1 ablation increases pluripotency marker expression. Control shRNA and Tet1 KD mESCs were differentiated for 7 days under atmospheric O~2~ and a cell lineage qPCR profiler array was performed upon pooled triplicate mRNA samples to give relative quantification of expression of (**A**) Pluripotency genes, (**B**) Endodermal-expressed genes, Mesodermal-expressed genes, and Ectodermal-expressed genes, (including neuronal progenitor markers). Data represent mRNA levels from Tet1 KD mESCs, expressed as a fold-change relative to corresponding expression in control mESCs, depicted by the dotted line (set at 1 in each case). Independent qPCR-validation of the mRNA levels of all pluripotency genes assessed genes are displayed as the mean ± SEM, analysed by an unpaired *t-*test. \**P* \< 0.05.](gkx1197fig5){#F5}

Tet3 is a genomic target of \[O~2~\]-regulated 5mC-hydroxylation during early mESC differentiation {#SEC3-6}
--------------------------------------------------------------------------------------------------

We sought to determine the genomic targets of the burst of 5hmC in differentiating mESCs at day 3 (cultured under atmospheric O~2~) by performing 5hmC DNA-immunoprecipitation (hMeDIP) followed by high throughput sequencing (hMeDIP-seq). We identified 610 gene loci which were \>2-fold enriched for 5hmC, compared to total genomic input (control) DNA ([Supplementary Table S1](#sup1){ref-type="supplementary-material"}). Functional annotation clustering of the enriched gene list, using The DAVID Gene Functional Annotation Tool (<http://david.ncifcrf.gov>), revealed the most enriched cluster, containing 55 genes, was associated with developmental and cell differentiation pathways. These sequencing data have been deposited in the Gene Expression Omnibus (GEO) database under accession number GSE107204. Unexpectedly, the most highly enriched sequences identified in these analyses mapped to a GC-rich promoter region of the *Tet3* gene locus which also comprises the expressed sequence tag, B230319C09Rik (Figure [6A](#F6){ref-type="fig"}). Strikingly, the number of sequencing reads at this region was greater than 7-fold higher than that at any other identified genomic locus ([Supplementary Table S1](#sup1){ref-type="supplementary-material"}). The mouse *Tet3* gene contains (at least) three distinct promoter regions ([@B52]), and the enriched sequences identified in this screen correspond to the most downstream of these three. To confirm this finding and to determine whether the levels of 5hmC at this locus were a result of *de novo* methylation and/or hydroxymethylation, during the mESC differentiation process, we performed bisulfite and oxidative-bisulfite sequencing on genomic DNA from both undifferentiated mESCs and day3-differentiated mESCs. We investigated the 5mC and 5hmC status of three specific CpG dinucleotides, identified within a 200 bp GC-rich genomic sequence of this *Tet3* promoter sequence. As shown in Figure [6B](#F6){ref-type="fig"}, in undifferentiated ESCs, all 3 CpG dinucleotides within this genomic region were (perhaps surprisingly) devoid of either 5mC or 5hmC epigenetic marks. However, at day 3 of mESC differentiation, all 3C residues demonstrated significant conversion to 5mC/5hmC, as determined by bisulfite sequencing (in each case, ∼60% conversion within the PCR amplicon, generated from the whole mESC population; arrowed in Figure [6B](#F6){ref-type="fig"}). Further, two of these CpG dinucleotides appeared hydroxymethylated, whereas the remaining CpG di-nucleotide appeared predominately methylated (arrowed in Figure [6B](#F6){ref-type="fig"}). The appearance of 5hmC at the *Tet3* promoter locus at day 3 of mESC differentiation was also confirmed by hMeDIP-PCR (Figure [6C](#F6){ref-type="fig"}) and was shown to be lost by culturing mESCs in 1% O~2~. We further assessed the occupancy of Tet1 at this locus by ChIP, and (by contrast to the appearance of the 5hmC mark), we found Tet1 to be bound to the *Tet3* promoter region both in undifferentiated and in day 3-differentiated mESCs (Figure [6D](#F6){ref-type="fig"}).

![Tet3 is the predominant target of the 5hmC burst in early-differentiating mESCs. (**A**) hMeDIP-seq was performed on day 3 mESC samples. A *Tet3* promoter region, co-incident with the expressed sequence tag, B230319C09Rik, was found to have the largest 5hmC enrichment, visualised using the Integrative Genome Viewer (IGV). (**B**) Bisulfite and oxidative-bisulfite chemistries confirmed the gain of 5hmC from undifferentiated to day 3 mESCs within the *Tet3* promoter region. Arrows after bisulfite treatment show the gain of methylation/hydroxymethylation on CpGs (5mC and 5hmC) at day 3. After oxidative-bisulfite treatment, the failure to convert cytosine to thymine is indicative of 5hmC at these CpGs sites. The remaining arrow demonstrates that 5mC is present on that CpG. (**C**) hMeDIP-PCR analyses of 5hmC enrichment on the *Tet3* promoter in mESC after 3 days of differentiation in atmospheric or 1% O~2~. (**D**) ChIP-PCR analyses of Tet1 occupancy at the *Tet3* promoter region in undifferentiated and day 3-differentiated mESCs, cultured under atmospheric O~2~, shown in each case relative to the respective IgG negative control. (**E**) qPCR analyses of Tet3 expression, normalised to that of Canx, in mRNA isolated from mESCs cultured under 1%, 3% and atmospheric O~2~, for times as indicated. Data expressed are expressed as the mean ± SEM and analysed by a two-way ANOVA with Tukey *post-hoc* test. \*\**P* \< 0.01, \*\*\*\**P* \< 0.0001.](gkx1197fig6){#F6}

We next determined the effect of \[O~2~\] upon Tet3 mRNA expression in differentiating mESCs. Many studies have suggested that the 5hmC epigenetic mark (which is reduced at the *Tet3* promoter region as a result of culture under low \[O~2~\]) to be involved in gene transcriptional activation ([@B17],[@B53]). mESCs induced to differentiate over a time course of 7 days were cultured in atmospheric, 3% or 1% O~2~ and Tet3 mRNA levels were compared at specific time points. As shown in Figure [6E](#F6){ref-type="fig"}, the levels of Tet3 at day 3 of mESC differentiation were, perhaps surprisingly, not reduced as a result of the more hypoxic culturing conditions (and in fact were increased at this point). However, by day 7, Tet3 mRNA levels *were* significantly decreased in cells grown in both 1% and 3% O~2~. Taken together, these data suggest that the \[O~2~\]-dependent 5mC-hydroxymethylation of the *Tet3* promoter region may act to 'mark' it for increased expression later during cellular differentiation and development.

Tet1 occupancy associates with both activating and repressive histone epigenetic marks at the Tet3 promoter in ESCs {#SEC3-7}
-------------------------------------------------------------------------------------------------------------------

The *Tet3* promoter region, identified here as a target of Tet1-mediated hydroxymethylation, comprises a highly GC-rich, CpG island (reviewed in ([@B54]). Virtually, all such promoters have been shown in ESCs to be marked by the activating, histone epigenetic mark; H3K4me4 ([@B55]). A subset of these gene promoters, termed 'bivalent' gene promoters, have additionally been shown to exhibit the repressive, H3K27me3 mark ([@B55]). Genes associated with such bivalent promoter regions typically include developmentally regulated genes, which are silenced in undifferentiated ESCs, but are poised to become activated as required at the appropriate stage of (cell type-specific) differentiation ([@B56]). Tet1 occupancy at regulatory CpG islands has been implicated in the generation of both the H3K4me3 and H3K27me3 histone marks, *via* the recruitment of the associated lysine methyltransferases; SET1A/B or mixed lineage leukemia (MLL), and Polycomb repressive complex 2 (PRC2), respectively ([@B30],[@B57]). We therefore investigated the occurrence of these histone modifications at the identified *Tet3* promoter. As shown in Figure [7A](#F7){ref-type="fig"}, both histone marks were clearly apparent at this locus in undifferentiated mESCs. At day 3 of differentiation, the H3K4me3 mark persisted (and the corresponding band representing this remained equally intense), whereas the H3K27me3 mark, although still present, appeared significantly decreased. These data therefore identify this *Tet3* gene locus as a Tet1-associated, bivalent promoter, and further suggest that the (partial) loss of the H3K27me3 mark at this locus is coincident with \[O~2~\]-dependent, Tet1-mediated 5mC-hydroxylation in differentiating mESCs (Figure [7B](#F7){ref-type="fig"}).

![The Tet3 promoter region is associated with activating and repressive histone marks. (**A**) ChIP-PCR analyses of the occurrence of H3K4me3 and H3K27me3 at the *Tet3* promoter region in undifferentiated and day 3-differentiated mESCs, cultured under atmospheric O~2~, shown in each case relative to the respective IgG negative control. (**B**) Schematic representation of proposed mechanism of \[O~2~\]-dependent regulation of *Tet3* and cellular differentiation. In undifferentiated mESCs, a GC-rich, *Tet3* promoter region is associated with Tet1. It is marked as a bivalent promoter by both active (H3K4me3) and repressive (H3K27me3) histone modifications and CpG dinucleotides are not methylated or 5mC-hydroxylated. As mESCs are induced to differentiate, *de novo* methylation of CpG dinucleotides provides the substrate for the catalytic activity of Tet1. Tet1 activity is induced in a graded manner, dependent upon the available \[O~2~\], and acts to generate 5hmC at CpG dinucleotides within the *Tet3* promoter. Concomitant with this the repressive H3K27me3 histone mark becomes lost, while the activating, H3K4me3 mark remains. *Tet3* is thus 'marked' to become expressed specifically in more O~2~-rich microenvironments (promoting neural differentiation).](gkx1197fig7){#F7}

DISCUSSION {#SEC4}
==========

The focus of this study was to investigate the potential role of Tets in mediating \[O~2~\]-dependent effects upon the differentiating mESC phenotype. Consistent with other studies in which low-O~2~ conditions were shown to skew cellular differentiation (reviewed in ([@B4],[@B6],[@B60])) we show here that culturing ESCs in 1% O~2~, compared to atmospheric (approximately 21%) O~2~, for 7 days resulted in the promotion of cells acquiring a mesodermal cell-lineage fate, and a concomitant inhibition of cells acquiring an ectodermal (and specifically neuronal) fate. The more hypoxic conditions also acted to promote the expression of pluripotency markers in the mESCs.

It is evident that epigenetic changes in chromatin architecture and DNA methylation underlie the determination of cell fate during cellular differentiation (reviewed in ([@B61])). Further, it is well documented that hypoxia can be sufficient to induce such epigenetic changes, notably as has been demonstrated in the progression of many cancers (reviewed in ([@B62],[@B63])). The absolute requirement of Tet enzymatic activity for O~2~ led us to determine whether Tets might, in part, mediate the O~2~-dependent regulation of mESC function and differentiation, *via* modulation of DNA methylation.

Tet1 is a potential O~2~-sensor in developing mammalian embryos {#SEC4-1}
---------------------------------------------------------------

We demonstrated that in HEK cells, Tet1 activity is differentially regulated at the low levels of O~2~ which are considered physiologically relevant in mammalian embryogenesis (0.5--5%; ([@B4],[@B6])). Consistent with our findings, the *K*~m~ value of (recombinant, purified) Tet1 for O~2~ was determined *in vitro* to be 30 μM, indicating that significant catalytic activity would be maintained at the relatively hypoxic environment of 3% O~2~, ([@B48]), while a separate *in vivo* study has demonstrated inhibition of Tet activity at 0.5% O~2~ ([@B64]). Intriguingly, we also demonstrated that the activities of the three individual Tet isoforms display distinct patterns of sensitivity to levels of both O~2~ and the TCA metabolites, fumarate and succinate, whose levels themselves may be dependent upon O~2~ availability. This is a potentially significant finding, which may in part underlie both the regulation of Tet-specific functions in other systems, and the cell-type-specific sensitivity to O~2~.

We analysed changes in global 5hmC (and 5mC) during the earliest stages of mESC differentiation, both by immuno-dot-blot analyses and by mass spectrometry. The results obtained from these separate analyses correlated extremely well, supporting the validity of these data. 5hmC levels within the mESCs were found here to be present at about 12% of the level of 5mC, and approximately 0.08% of that of total C (data not shown), in broad agreement with a previous study ([@B22]). We observed a novel, transient burst of 5hmC which peaked at day3 and was inhibited significantly by culturing the differentiating mESCs in 1% O~2~. Tet1 was identified as the enzyme which primarily mediated this burst of 5mC-hydroxylation. We therefore propose that the activity of Tet1 within the early-developing embryo may be graded, dependent upon the cellular availability of O~2~, and thus propose Tet1 to act as an O~2~ sensor ([@B65]).

Temporal regulation of Tet activity during mESC differentiation {#SEC4-2}
---------------------------------------------------------------

A clear anomaly in our data is the observation that Tet1 (and Tet2) expression levels are decreasing at a time when the catalytic capacity is seen to increase (at day 3 of differentiation). Several studies have suggested Tet1 to serve non-catalytic functions, involved in the recruitment and maintenance of other chromatin modelling enzymes to specific regulatory DNA regions ([@B30],[@B59]). Perhaps consistent with this, Tet1 was found here to be bound to the *Tet3* promoter region in undifferentiated mESCs, in the absence of 5hmC at this locus (Figure [6D](#F6){ref-type="fig"}). It is also likely that the lack of 5hmC at the Tet3 locus is a reflection of the low global levels of the Tet substrate; 5mC, in the mESCs, due to their culture under 2i conditions ([@B49]). As the cells are induced to differentiate in the absence of 2i, 5mC levels then rise, providing the substrate for Tet activity. However, it should be noted that another (CpG-poor) gene loci; *Orm1*, which has previously been reported to be constitutively methylated in mESCs ([@B66]), was also found to be methylated (but not hydroxymethylated) in our undifferentiated mESCs (data not shown), consistent with methylation remaining in some loci within ESCs cultured under 2i-conditions ([@B67]).

In addition, the activities of the Tets have been shown to be upregulated significantly by ascorbic acid (vitamin C; AA), by virtue of their requirement for Fe^2+^ ([@B68],[@B69]). AA acts to recycle (oxidised) Fe^3+^ to the reduced Fe^2+^ form, and we note that the addition of AA to the undifferentiated mESCs was sufficient to induce a small yet significant increase in 5hmC levels in these cells, again suggesting the occurrence of detectable levels of existing 5mC ([Supplementary Figure S3](#sup1){ref-type="supplementary-material"}).

We also investigated whether changes in cellular AA levels (potentially resulting from the KnockOut Serum Replacement ([@B68]), in which the mESCs were induced to differentiate) might also be responsible for the increased Tet activity seen at day 3 of differentiation. However, the addition of the ascorbate transporter inhibitor, phloretin ([@B70]) did *not* decrease the levels of 5hmC in the differentiating mESCs ([Supplementary Figure S3](#sup1){ref-type="supplementary-material"}). Further, when the undifferentiated cells were cultured in KnockOut serum (rather than EmbryoMax), the levels of 5hMC were still seen to significantly increase upon differentiation at day 3 (in KnockOut serum; [Supplementary Figure S4](#sup1){ref-type="supplementary-material"}).

The precise molecular mechanisms which underlie the increased Tet activity, as Tet expression levels fall, therefore remain unclear. To our knowledge, this transient increase in 5hmC levels has not previously been reported in early differentiating mESCs *in vitro*. However, recently a Tet1-dependent transient burst of 5mC-hydroxylation was observed *in vivo*, in the mouse E6.5 epiblast ([@B33]). Further, in this study, Tet1 was demonstrated to serve a non-redundant role in the early embryo, as genetic ablation of Tet1 resulted in embryonic defects at gastrulation. The possibility that this function of Tet1 may in part be \[O~2~\]-dependent at this early stage in the embryo is clearly intriguing and will be the focus of future studies.

Tet3 is a target of \[O~2~\]- dependent 5hmC-hydroxylation {#SEC4-3}
----------------------------------------------------------

A particularly interesting (and unexpected) finding of this study was that the most significant target of 5mC-hydroxylation in the early-differentiating mESCs was a promoter region within the *Tet3* gene locus. We demonstrated that this hydroxymethylation occurred *de novo*, after the cells were induced to differentiate, consistent with its occurrence as a part of the 'burst' of 5mC-hydroxylation apparent at the day 3 time point. Perhaps surprisingly, we found no evidence of methylation at the CpG dinucleotides investigated, in undifferentiated mESCs. It is therefore possible that the methylation and hydroxymethylation reactions are closely coupled in these cells, as suggested above.

Levels of 5hmC at the *Tet3* promoter locus were lost when the mESCs were differentiated under more hypoxic culture conditions (1% O~2~). Further, we demonstrated by ChIP that this region is associated with Tet1, and that this association was also apparent in undifferentiated mESCs. However, it should be noted that we have been unable to demonstrate a loss of 5hmC at this site in the Tet1-ablated mESCs, after 3 days of differentiation (at atmospheric O~2~). We suggest that this may result from functional compensation by Tet2 (which is also abundantly expressed in the mESCs) and/or functional redundancy between Tet1 and Tet2, as has been reported previously in mESCs ([@B71],[@B72]). None-the-less, together, our data strongly support that in wild-type (wt) mESCs, the 5mC-hydroxylation of the *Tet3* promoter is predominantly mediated by Tet1, and is differentially regulated within a gradient of \[O~2~\].

The *Tet3* promoter region, targeted for 5mC-hydroxylation, displays the characteristics of a GC-rich, bivalent promoter, being associated with both activating (H3K4me27) and repressive (H3K27me3) histone epigenetic marks. Tet1 occupancy and activity has been demonstrated previously at such promoters ([@B59],[@B73],[@B74]), which are suggested to maintain developmental stage- and tissue-specific genes in a silent state in ESCs, yet poised for subsequent activation upon differentiation (reviewed in ([@B58]). Consistent with this, our data suggest that Tet3 mRNA expression is low in undifferentiated, wt mESCs and is strongly induced between day 3 and day 7 of differentiation (in culture under atmospheric O~2~). Inhibition of 5mC-hydoxylation at the *Tet3* promoter region, by culture in low (1% or 3%) O~2~, resulted in a significant blunting of this transcriptional activation. Several studies have demonstrated the critical role of Tet3 in neural development ([@B25],[@B75]), and it is therefore potentially significant that the culture of differentiating mESCs in 1% O~2~ was also shown here to inhibit the expression of early neuronal markers.

Roles of Tet1 in neural development and function have also been demonstrated ([@B25],[@B35],[@B36]), and data presented here suggest a functional interdependence between two Tet enzymes, in which the activity of Tet1 potentiates the transcriptional activation of *Tet3*. The specific region within *Tet3*, targeted for 5hmC-hydroxylation, corresponds to the promoter region spanning the transcriptional start site(s) for an isoform of Tet3 which lacks the N-terminal, CXXC, DNA-binding domain ([@B52]). Several studies have demonstrated the different functional requirements for this truncated protein, compared the longer isoform, in particular in neuronal specification and phenotype ([@B52],[@B76]). It is thus possible that the Tet1-mediated hydroxymethylation described here may play a role in the relative transcription patterns of the different Tet3 isoforms, in differentiating mESCs.

The downregulation of Tet1, however was not sufficient to completely mirror the effects of low \[O~2~\] upon neuronal expression during mESC differentiation (Figure [5B](#F5){ref-type="fig"}), Again, functional redundancy between Tet1 and Tet2 may in part explain this ([@B71],[@B72]), and in addition other O~2~-dependent processes are clearly likely also to function in the regulation of cellular differentiation, such as histone demethylation by members of the Jumonji protein family ([@B77]). Never-the-less, both low O~2~ (1%) and Tet1-downregulation resulted in some increased expression of all pluripotency markers (which, in the cases of Dnmt3b and Oct4, reached significance) in differentiating mESCs, suggesting a non-redundant (potentially \[O~2~\]-dependent) role for Tet1 in mESC self-renewal.

To conclude, we demonstrate here the potential for the catalytic function of Tet1 to be differentially activated in response to a gradient of O~2~, at (low) levels which are physiologically relevant to the early developing embryo (0.5--5%). We demonstrate that differentiating mESCs exhibit an early burst of \[O~2~\]-regulated 5mC-hydroxylation that is predominantly mediated by Tet1. In addition, we identify a GC rich, bivalent *Tet3* promoter region as a target of this \[O~2~\]-regulated 5mC-hydroxylation. Based on these data we propose that gradients of available O~2~ result in the non-uniform catalytic activity of Tet1 within the early embryo. As a consequence, this *Tet3* promoter region becomes 5mC-hydroxylated, and 'marked' for transcriptional activation (later in differentiation) only in specific regions of the embryo with adequate available O~2~. This \[O~2~\]-dependent transcriptional regulation of Tet3 may be an important mediator of cellular fate, and in particular neuronal differentiation, during the earliest stages of embryonic development (Figure [7B](#F7){ref-type="fig"}).
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